MedTrace Logo

PSA TOOL for Prostate Cancer Screening Discussions

NCT03135444 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2018-05-11

No results posted yet for this study

Summary

The study team created a tool to help identify patients who may benefit from shared decision making in the primary care setting. This tool is a guide to aid in decision making for prostate cancer screening. The team proposes the topics to be discussed in the screening conversation include the risk for developing prostate cancer based upon age, race/ethnicity, family history of prostate cancer, history of previous digital rectal exam, and history of previous prostate specific antigen (PSA) as well as self-reported health status and preferences for treatment. The team now proposes 1) testing this tool first for ease of use in primary care clinics 2) revising this tool based upon feedback from patients and providers, then 3) testing this tool for effectiveness in improving patient knowledge that they have an option to be screened for prostate cancer and of specific factors to be considered in the screening decision.

Conditions

Interventions

BEHAVIORAL

PSA TOOL

Providers will be given the initial PSA TOOL and will be asked to give their feedback to revise the tool.

BEHAVIORAL

Revised PSA TOOL

Patients will be given the revised PSA TOOL, after providers have given their initial feedback.

BEHAVIORAL

Informal Interview

Both patients and providers will have informal interviews with the study team to get feedback on the survey taking process.

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Anita Misra-Hebert, MD, MPH · Cleveland Clinic, Case Comprehensive Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
40 Years
Max Age
69 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-02
Primary Completion
2017-12-13
Completion
2018-04-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03135444 on ClinicalTrials.gov